Skip to content
Search

Latest Stories

WHO stops hydroxychloroquine trials over safety concerns

THE WHO suspended trials of the drug that Donald Trump has promoted as a coronavirus defence, fuelling concerns about the US president's handling of the pandemic that has killed nearly 100,000 Americans.

Trump has led the push for hydroxychloroquine as a potential shield or treatment for the virus, which has infected nearly 5.5 million people and killed 345,000 around the world, saying he took a course of the drug as a preventative measure.


Brazilian president Jair Bolsonaro has also heavily promoted hydroxychloroquine while the virus has exploded across nation, which this week became the second most infected in the world after the US.

But the World Health Organization said Monday (25) it was halting testing of the drug for COVID-19 after studies questioned its safety, including one published Friday that found it actually increased the risk of death.

The WHO "has implemented a temporary pause... while the safety data is reviewed", its chief Tedros Adhanom Ghebreyesus said, referring to the hydroxychloroquine arm of a global trial of various possible treatments.

Trump announced last week he was taking the drug, explaining he had decided to take after receiving letters from a doctor and other people advocating it.

"I think it's good. I've heard a lot of good stories," Trump told reporters then, as he declared it safe.

Trump dismissed the opinions then of his own government's experts who had warned of the serious risks associated with hydroxychloroquine, with the Food and Drug Administration highlighting reported poisonings and heart problems.

Trump has been heavily criticised for his handling of the virus, after initially downplaying the threat and then repeatedly rejecting scientific analysis.

The US has by far the world's highest coronavirus death toll, reaching 98,218 on Monday, with more than 1.6 million confirmed infections.

Despite the WHO suspension, Brazil's health ministry said Monday it would keep recommending hydroxychloroquine for COVID-19.

"We're remaining calm and there will be no change," health ministry official Mayra Pinheiro told a news conference.

Bolsonaro is a staunch opponent of lockdown measures and like Trump has played down the threat of the virus, even as Latin America has emerged as the new global virus hotspot.

Brazil has reported nearly 375,000 cases, widely considered to be far fewer than the real number because of a lack of testing, and more than 23,000 deaths.

Chile also is in the grip of a virus surge, with a record of nearly 5,000 infections in 24 hours on Monday.

While South America and parts of Africa and Asia are only just beginning to feel the full force of the pandemic, many European nations are easing lockdowns as their outbreaks are brought under control.

In hard-hit Spain, Madrid and Barcelona on Monday emerged from one of the world's strictest lockdowns, with parks and cafe terraces open for the first time in more than two months.

Elsewhere, gyms and swimming pools reopened in Germany, Iceland, Italy and Spain.

More For You

Crispello Comeback: Cadbury’s Light Treat Hits B&M Shelves

The return to UK shelves has brought a wave of nostalgia for many

Getty

Cadbury Crispello chocolate bars return to UK shelves at B&M for 49p

Cadbury's Crispello chocolate bars have made a surprise return to UK stores, now available at B&M for just 49p. The product, a mix of light wafer and smooth chocolate, had previously been discontinued in the UK and was only available overseas in recent years.

Each individual pack of Crispello contains four chocolate-covered wafer fingers, filled with a creamy chocolate centre. The sweet treat has gained attention on social media, with shoppers expressing their excitement about its reappearance in British stores.

Keep ReadingShow less
 Sharon Osbourne

Celebrities including Sharon Osbourne and Oprah Winfrey might be exhibiting signs of this side effect

Instagram/ Sharonosbourne

‘Ozempic feet’ joins growing list of unusual side effects linked to popular weight-loss drug

Ozempic, the blockbuster weight-loss medication that has surged in popularity across the United States and among celebrities, is now being linked to a new and unexpected side effect like sagging skin on the feet, informally dubbed “Ozempic feet”.

Medical experts say the condition is caused by rapid fat loss, which not only alters the appearance of the face and buttocks, but can also lead to aesthetic changes in the feet. As the drug continues to make headlines for its weight-loss benefits, concerns about such side effects are also gaining attention.

Keep ReadingShow less
MRI

Individuals with certain metabolic conditions may be more prone to this process

Getty

MRI injection linked to rare deadly health risk, study finds

A new study has raised concerns over the use of a common chemical injected during MRI scans, suggesting it may contribute to a potentially fatal complication in rare cases.

Researchers from the University of New Mexico have found that gadolinium – a toxic rare earth metal used in MRI contrast agents – can interact with oxalic acid found in many foods to form nanoparticles in human tissues. These particles could potentially lead to serious health problems affecting organs such as the kidneys.

Keep ReadingShow less
Morrisons

Morrisons has said it will continue to monitor customer feedback

Getty

Morrisons adds charity donation option to More Card loyalty scheme

Morrisons has announced a new update to its More Card loyalty programme, giving customers the option to donate their points to charity. The change, introduced on Monday 14 April, allows shoppers to convert their saved points into cash donations for Marie Curie, a UK charity that provides end-of-life care and support.

Under the new scheme, customers can donate their points in multiples of 1,000, which equates to a £1 value. Donations can be made easily through the More Card app or the official Morrisons website. Once submitted, the points are converted into their cash equivalent and passed directly to Marie Curie on behalf of the customer.

Keep ReadingShow less